Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

During the Trading Day
250.77 -13.09 / -4.96%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
250.00 -0.77 / -0.31%
 
Volume: 31.9K

Today’s Trading

Previous close263.86
Today’s open260.45
Day’s range248.16 - 260.45
Volume2,758,161
Average volume (3 months)2,390,090
Market cap$57.7B
Dividend yield--
Data as of 4:14pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+9.52%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+11.01%
P/E ratio16.4
Price/Sales6.58
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc-1.52-4.00%
BAXBaxter International...-1.49-3.97%
AMGNAmgen-2.04-1.41%
XONIntrexon Corp-0.95-2.64%
Data as of 4:14pm ET, 02/08/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$4.46
Annual revenue (last year)$10.8B
Annual profit (last year)$3.5B
Net profit margin32.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Senior Medical Director
Diego Cadavid
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers